Urology Product Segment
Focused portfolio for BPH, UTI, Kidney Stones, Erectile Dysfunction, Overactive Bladder.
Therapeutic Areas Covered
- Benign Prostatic Hyperplasia (BPH)
- Urinary Tract Infections (UTI)
- Kidney Stones Management
- Erectile Dysfunction
- Overactive Bladder & Incontinence
Key Molecules
- Silodosin 4 mg / 8 mg
- Silodosin + Dutasteride
- Tadalafil
- UTI Antibiotic Range
Quality Commitment
All products are manufactured in WHO-GMP certified facilities with strict quality monitoring.
Silodosin 4mg / 8mg
For treatment of Benign Prostatic Hyperplasia (BPH) with high prostate volume reduction outcomes.
BPH
Silodosin + Dutasteride
Combination therapy for sustained BPH relief and long-term prostate health.
BPH
Tadalafil
Urology-grade formulation for erectile dysfunction and symptomatic relief in BPH.
ED
UTI Antibiotic Range
Broad-spectrum urinary tract infection therapy with optimized dosing for compliance.
UTI
IncontiRelief
Overactive bladder and incontinence management formula.
Overactive bladder
StoneDissolve
Supportive therapy for kidney stone dissolution and pain reduction.
Kidney stonesFor detailed product specification, doctor information, or distribution details, connect with us on Contact page.